LAX.SH
ASTEC LIFESCIENCES LTD·PESTICIDES 28.50·Fertilizers & Agrochemicals Companies
Price
669.2
+0.49%52W Range
Market Cap
₹1,491.17 Cr
Traded: ₹4.28 Cr (0.29%) 0.0x
Free Float: ₹352.51 Cr (1.22% of FF traded)
Volume · 60D trend
62.7 K 0.0x
Delivery: % 0.0x
View Delivery Data
Returns
RS Score
Create a free account to unlock your edge
Scanners, market pulse, FII/DII data, and TradingView charts — free forever
Valuation
Business Strength
Growth (3Y CAGR)
Balance Sheet
Cash Position
Others
MTF Exposure Trend
60 sessions · funded amount, % of FF, daily delta
LAX.SH
Growth Trends
| Metric | 10Y | 5Y | 3Y | 1Y | TTM | Trend |
|---|---|---|---|---|---|---|
| Sales | +7.0% | -4.0% | -11.0% | -- | +9.0% | Stable |
| ROE | +2.0% | -8.0% | -26.0% | -- | -- | Decelerating |
| Return | +6.0% | -14.0% | -20.0% | -28.0% | -- | Decelerating |
| Profit | -- | -- | -- | -- | +50.0% | -- |
Quarterly Results
Mar 2023
Dec 2022
Revenue & Margin Trends
Annual
Quarterly
Balance Sheet Health
Leverage
Efficiency
Cash Position
Detailed Financials
Jun 2026PDF ↗ | Mar 2026PDF ↗ | Dec 2025PDF ↗ | Sep 2025PDF ↗ | Jun 2025PDF ↗ | Mar 2025PDF ↗ | Dec 2024PDF ↗ | Sep 2024PDF ↗ | Jun 2024PDF ↗ | Mar 2024PDF ↗ | Dec 2023PDF ↗ | Sep 2023PDF ↗ | Jun 2023PDF ↗ | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 84 | 159 | 125 | 74 | 91 | 120 | 94 | 99 | 69 | 154 | 51 | 111 | 143 | 127 | 117 |
| Expenses | 84 | 149 | 121 | 80 | 102 | 114 | 100 | 118 | 116 | 141 | 69 | 114 | 140 | 122 | 105 |
| Operating Profit | -1 | 9 | 4 | -7 | -11 | 6 | -6 | -20 | -46 | 13 | -18 | -3 | 3 | 5 | 12 |
| Other Income | 1 | 3 | -1 | 1 | 1 | 1 | 2 | 2 | 1 | 2 | 1 | 1 | 2 | 3 | 4 |
| Interest | 8 | 8 | 7 | 8 | 11 | 10 | 10 | 9 | 7 | 7 | 6 | 6 | 6 | 6 | 6 |
| Depreciation | 11 | 12 | 11 | 10 | 11 | 12 | 11 | 11 | 9 | 9 | 9 | 9 | 9 | 8 | 9 |
| Profit Before Tax | -19 | -8 | -16 | -24 | -33 | -16 | -25 | -39 | -62 | -1 | -32 | -18 | -11 | -6 | 1 |
| Tax % | 0.0% | -2.0% | 0.0% | 0.0% | 0.0% | 3.0% | 61.0% | 0.0% | -36.0% | 4.0% | -24.0% | -24.0% | -26.0% | -19.6% | 31.0% |
| Net Profit | -19 | -8 | -16 | -24 | -33 | -16 | -40 | -39 | -40 | -1 | -24 | -13 | -8 | -5 | 1 |
| Exceptional Items | 0 | 0 | -2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Rs) | -8.4 | -3.5 | -7.0 | -11.0 | -14.8 | -7.2 | -18.0 | -17.2 | -17.7 | -0.4 | -10.9 | -6.0 | -3.7 | -2.2 | 0.4 |
| Sales Growth (YoY) | -7.7% | 32.5% | 33.0% | -25.3% | 31.9% | -22.1% | 84.3% | -10.8% | -51.8% | 21.3% | -56.4% | -- | -- | -- | -- |
| Sales Growth (QoQ) | -47.2% | 27.2% | 68.9% | -18.7% | -24.2% | 27.7% | -5.0% | 43.5% | -55.2% | 202.0% | -54.0% | -22.4% | 12.6% | 8.5% | -- |
| OP Growth (YoY) | 90.9% | 50.0% | 166.7% | 65.0% | 76.1% | -53.8% | 66.7% | -566.7% | -1633.3% | 140.3% | -250.0% | -- | -- | -- | -- |
| OP Growth (QoQ) | -111.1% | 125.0% | 157.1% | 36.4% | -283.3% | 200.0% | 70.0% | 56.5% | -453.8% | 172.2% | -500.0% | -200.0% | -44.5% | -54.9% | -- |
| Profit Growth (YoY) | 43.3% | 51.8% | 66.3% | 36.6% | 16.8% | -1558.8% | -66.0% | -187.1% | -385.0% | 80.5% | -2996.4% | -173.3% | -171.8% | -112.0% | -97.0% |
| EPS Growth (YoY) | 43.0% | 51.5% | 60.9% | 36.3% | 16.8% | -1569.8% | -66.0% | -186.8% | -384.4% | 80.6% | -2957.9% | -- | -- | -- | -- |
| EPS Growth (QoQ) | -141.4% | 50.6% | 35.7% | 25.7% | -105.4% | 60.2% | -4.8% | 2.9% | -4023.3% | 96.0% | -81.0% | -63.9% | -64.9% | -684.2% | -- |
| OP Margin | -1.2% | 5.7% | 3.2% | -9.5% | -12.1% | 5.0% | -6.4% | -20.2% | -66.7% | 8.4% | -35.3% | -2.7% | 2.1% | 4.3% | 10.3% |
| Net Margin | -22.6% | -5.0% | -12.8% | -32.4% | -36.3% | -13.3% | -42.5% | -39.4% | -58.0% | -0.7% | -47.1% | -11.7% | -5.6% | -3.9% | 0.8% |
| Material Cost % | -- | 70.0% | 66.0% | 56.0% | 70.0% | 62.0% | 66.0% | 81.0% | 118.0% | 68.0% | 70.0% | 69.0% | 72.0% | 68.0% | 60.0% |
| Employee Cost % | -- | 10.0% | 13.0% | 21.0% | 17.0% | 12.0% | 17.0% | 15.0% | 23.0% | 10.0% | 28.0% | 16.0% | 11.0% | 10.0% | 10.0% |
| P/S | 3.37 | 3.12 | 4.08 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/E | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/B | 3.82 | 3.58 | 4.04 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Exchange Filings
50Astec Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/10/2026 ,inter alia, to consider and approve Please find enclosed intimation.
Please find enclosed, certificate for the Quarter ended September 30, 2026.
The Exchange has sought clarification from Astec Lifesciences Ltd on October 1, 2026, with reference to Movement in Volume.<BR><BR>The reply is awaited.
Please find enclosed, Company''s response.
Please find enclosed, intimation of closure of trading window.
Please find enclosed, Company''s response.
The Exchange has sought clarification from Astec Lifesciences Ltd on September 18, 2026, with reference to Movement in Volume.<BR><BR>The reply is awaited.
Please find enclosed, our response to BSE e-mail dated September 10, 2026.
The Exchange has sought clarification from Astec Lifesciences Ltd on September 10, 2026 with reference to significant movement in price, in order to ensure that investors have latest relevant ....
Please find enclosed, our response.
The Exchange has sought clarification from Astec Lifesciences Ltd on September 09, 2026, with reference to Movement in Volume. <BR><BR>The reply is awaited.
Please find attached the financial results for the Quarter ended June 30, 2026
Please find enclosed, AGM proceedings, Scrutinizer''s Report, Annual Report and Voting Results.
Please find enclosed, AGM proceedings, Scrutinizer''s Report, Annual Report and Voting Results.
Astec Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2026 ,inter alia, to consider and approve Standalone and Consolidated ....
Please find enclosed, compliance certificate.
Please find enclosed, copies of newspaper publication.
Please find enclosed Intimation.
Please find enclosed Intimation.
Intimation regarding Closure of Register of Members and Share Transfer Book.
Please find enclosed Intimation of Annual General Meeting and Annual Report of Financial Year 2025-26
Please find enclosed .
Please find enclosed, intimation of Postal Ballot.
Please find enclosed, intimation regarding Postal Ballot.
Please find enclosed, intimation regarding Postal Ballot.
Please find enclosed the Outcome of Postal Ballot
Please find enclosed, intimation of Scrutinizer''s Report of Postal Ballot.
Please find attached Intimation of Closure of Trading Window.
Please find enclosed Newspaper Publication.
Please find enclosed intimation.
Please find enclosed intimation regarding Postal Ballot notice.
The Exchange has sought clarification from Astec Lifesciences Ltd on June 01, 2026, with reference to Movement in Volume. <BR><BR>The reply is awaited.
Please find enclosed reply on significant increase in the volume of security.
Please find enclosed Intimation.
Please find enclosed copy of newspaper publication.
Please find enclosed, notice to the Shareholders of the Company for transfer of Unclaimed Dividend and Equity Shares to Investor Education and Protection Fund (IEPF)
Please find enclosed intimation regarding Grant of Stock Options.
Please find enclosed Newspaper Publication.
Please find Enclosed Press Release
The 32nd AGM of the Company will be held on 31st July, 2026.
Please find enclosed Outcome of Board Meeting
Please find enclosed Audited Financial Results of the Company for the Quarter and the Financial Year ended March 31, 2026
Please find Attached Intimation of Book Closure
Please find enclosed clarification letter.
The Exchange has sought clarification from Astec Lifesciences Ltd on April 17, 2026 with reference to significant movement in price, in order to ensure that investors have latest relevant ....
Astec Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/04/2026 ,inter alia, to consider and approve Audited Financial Results ....
Please find enclosed, Outcome of the Board Meeting.
Please find enclosed, Outcome of Board Meeting.
Please find enclosed Certificate under SEBI (Depositories and Participants) Regulations, 2018.
Please find enclosed intimation of Payment of Interest on Non-Convertible Debentures.
Annual Reports
15Credit Ratings
6Concalls
6Nov 2022
30 Nov 2022Nov 2022
30 Nov 2022May 2022
31 May 2022Nov 2021
30 Nov 2021Aug 2021
31 Aug 2021Feb 2021
28 Feb 2021Held by Mutual Funds
3 schemes hold astec · sorted by weight